Global and China Insulin Industry Report, 2013 - 2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing market size. In 2012 the global insulin market size reached US$20.8 billion, a year-on-year rise of 12.9%, basically monopolized by Novo Nordisk, Sanofi and Eli Lilly, which altogether accounted for 88.7% of market share.
Being the biggest diabetes power in the world, China currently has 98.4 million patients, accounting for about 25.8% of the world&rsqu... Click here for more details

GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre

GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers

GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie

GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market

GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u

GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-

Related News

China, which has been focusing on alternate industries in efforts to shift from traditional commodities such as iron, coal and ore, is showing interest in the Australian dairy industry. In its bid to safeguard supplies for its 1.3 billion people and provide them with secure and safe food resources, China has been investing more on agriculture industries.
Australia’s agricultural sector which has been an investment focus of CIC (China Investment Corp.) is a high-tension sector and invest

Date: Sep 26

Upcoming Reports

Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma

An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti

Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque

Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal

Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr

The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i

The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog

The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali

The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices

The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar